Bone Growth Articles & Analysis
21 news found
The company intends to pursue multiple applications in the distal extremity, trauma, sports, reconstruction, pediatrics and spine segments. About OSSIOfiber Intelligent Bone Regeneration Technology Designed for rapid bone in-growth, regeneration and replacement, OSSIOfiber Intelligent Bone Regeneration Technology is a ...
This is the third FDA clearance for the company’s OSSIOfiber® Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative material to provide stability and secure bone fixation while leaving no permanent hardware behind. ...
Based on more than a decade of extensive research – the EMPOWR 3D Knee® improves clinical outcomes.2,5 DJO’s proprietary P2™ coating on the EMPOWR Porous® Knee aids in the apposition of bone for excellent in-growth ...
The data demonstrate that elderly patients in Denmark treated with i-FACTOR bone graft plus local bone had a statistically significantly higher fusion rate compared to allograft plus local bone. ...
P-15L Bone Graft is based on a small biomimetic peptide (P-15) technology developed by Cerapedics to support bone growth, and is designed to be used as a substitute for autologous bone. In 2015, the company’s first-generation bone graft became the first bone graft to be approved for use in ...
“An indication for the use of P-15L Bone Graft in lumbar spine fusion would unlock a significant addressable market expansion opportunity that represents 80% of the total bone graft market. ...
First use of a nanotechnology enhanced pedicle screw with label claims to increase and accelerate human osteoblast and mesenchymal stem cell calcified extracellular matrix production in vitro CARMEL, Ind., Sept. 28, 2021 - Nanovis, an award winning technology company with unique and differentiated nanotechnology surfaces for improving bone growth and fighting ...
ByNanovis
i-FACTOR Peptide Enhanced Bone Graft must be used inside an allograft bone ring and with supplemental anterior plate fixation. About Cerapedics Cerapedics is an ortho-biologics company focused on developing and commercializing its proprietary small peptide (P-15) technology platform. i-FACTOR Peptide Enhanced Bone Graft is the only biologic ...
-based biopharmaceutical company has discovered and patented a novel molecular pathway intended to treat metastatic bone lesions Latest patent issuance follows previous patents for methods in stimulating bone growth, promote controlled bone creation and repair of large segmental bone defects using ZetaMet™ ...
” i-FACTOR+ MATRIX utilizes a small proprietary peptide (P-15) technology developed by Cerapedics to support bone growth through cell attraction, attachment, and activation. Cerapedics initial P-15 technology product, i-FACTOR Peptide Enhanced Bone Graft, was approved in the European Union in 2008 and Australia in 2010 for use in the ...
Importantly, nanotexturing below 100 nanometers has been shown to be beneficial to osteoblast functions that are necessary to grow bone and promote fusion.2,3 PEEKplus is not a coating, it is not porous, and no chemicals are infused into the PEEK. ...
” “In addition to an anticipated commercial launch in Canada this October, the technology is currently being studied in our FDA IDE study, ASPIRE, targeting lumbar fusions (TLIF), as previously announced. i-FACTOR+ Matrix is the same technology as the P15-L investigational material in the IDE.,” said Jeffrey Marx, Ph.D., President and Chief Operating Officer of Cerapedics. ...
The patent, entitled Composition and Methods to Promote Bone Formation, covers the use of methods for stimulating bone growth using the Company’s small molecule, ZetaMet™. ...
Carmel, Indiana (July 14, 2020) – Nanovis, a unique technology company focused on nanotechnology for improving bone growth and fighting infection, today reported a record sales month in June 2020. ...
ByNanovis
” Cerapedics commercialized i-FACTOR Bone Graft beginning in 2016. The drug-device combination is based on synthetic small peptide (P-15) technology that accelerates new bone formation in patients with degenerative disc disease. ...
” – Douglas Pahl, MD, Todd Bonvallet, MD, The Hughston Clinic, Columbus, GA “The FortiCore scaffold has performed well for my patients in lumbar and cervical fusions, providing a large area of highly porous, nanotube enhanced surface for bone to interface with before bone has time to grow through the implant. ...
ByNanovis
HCCP technology serves as the platform for MMI’s bone regeneration product, Osteo-P™ Bone Graft Substitute (BGS). More than 1 million bone grafts are performed worldwide each year, and the demand for more effective bone graft replacements is increasing. Various types of bone graft substitutes such as ...
-based biopharmaceutical company has discovered and patented a novel molecular pathway intended to treat metastatic bone lesions Latest patent issuance follows previous patents for methods in stimulating bone growth using ZetaMet™ New patent further enhances the Company’s Global IP strategy Zetagen Therapeutics, Inc., a private, ...
These patents, entitled Composition and Methods to Promote Bone Formation, include claims covering the use of methods for stimulating bone growth using its novel molecular pathway, ZetaMet™. ...
The ceramic nanosurfacing technology dovetails with Nanovis’ technology, offering a range of spinal implant nanosurfaces designed to increase bone to implant growth. The addition of ceramic nanosurfacing allows Nanovis to extend its lead in the development of superior fixation technology for medical implants with greater strength, osseointegration and ...
ByNanovis